Comparison of the Mean Duration of 3rd Stage of Labour Between Intraumbilical and Intravenous Oxytocin

NCT07053930 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-07-08

No results posted yet for this study

Summary

There is always a debate for choosing the best method for management of the third stage of labour (TSL) in the general practice for reducing the duration of TSL. Although intravenous oxytocin is more extensively used in general practice for managing TSL than intraumbilical, it still needs to be properly investigated among local populations and in local settings.

Conditions

  • Labor

Interventions

DRUG

Intraumbilical oxytocin

Patients were given 10 U of intraumbilical oxytocin, diluted in 10 mL of normal saline.

DRUG

Intravenous oxytocin

Patients received 20 U of intravenous oxytocin diluted in 500 mL of normal saline.

Sponsors & Collaborators

  • RESnTEC, Institute of Research

    lead OTHER

Principal Investigators

  • Anam Javed · Sadiq Abbasi Hospital, Bahawalpur, Pakistan

  • Komal Iqbal · Sadiq Abbasi Hospital, Bahawalpur, Pakistan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-01
Primary Completion
2025-03-31
Completion
2025-03-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07053930 on ClinicalTrials.gov